Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAP-1502 spray for adult scalp psoriasis
ChiCTR2600120718Phase 3Not yet recruiting
- Sponsor
- Peking University People's Hospital
- Start
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in psoriasis comparing TAP-1502 spray 1% with Placebo spray (2 arms). Primary endpoint: Scalp PGA response rate at day 84. Planned start Mar 2026; status: not yet recruiting.
02
Drugs
TAP-1502
03
Conditions
psoriasis
Beyond the preview
Go deeper on ChiCTR2600120718.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600120718.